During the past decade, Tuscaloosa VA Medical Center, Tuscaloosa, AL conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 21 clinical trials were completed, i.e. on average, 140% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 5 clinical trials were completed. i.e. 62.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tuscaloosa VA Medical Center, Tuscaloosa, AL" #1 sponsor was "VA Office of Research and Development" with 16 trials, followed by "US Department of Veterans Affairs" with 9 trials sponsored, "Tuscaloosa Research & Education Advancement Corporation" with 6 trials sponsored, "National Institute of Mental Health (NIMH)" with 3 trials sponsored and "Otsuka Pharmaceutical Development & Commercialization, Inc." with 3 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tuscaloosa VA Medical Center, Tuscaloosa, AL" #1 collaborator was "Tuscaloosa Veterans Affairs Medical Center" with 3 trials as a collaborator, "Acorda Therapeutics" with 2 trials as a collaborator, "Janssen, LP" with 2 trials as a collaborator, "Ralph H. Johnson VA Medical Center" with 2 trials as a collaborator and "United States Department of Defense" with 2 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Tuscaloosa VA Medical Center, Tuscaloosa, AL" are "PTSD" (8 trials), "Posttraumatic Stress Disorder" (5 trials), "Dementia" (3 trials), "Major Depressive Disorder" (3 trials) and "Alzheimer's Disease" (2 trials). Many other conditions were trialed in "Tuscaloosa VA Medical Center, Tuscaloosa, AL" in a lesser frequency.

Most popular intervention types in "Tuscaloosa VA Medical Center, Tuscaloosa, AL" are "Drug" (24 trials), "Behavioral" (12 trials) and "Other" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Individual Placement and Support (IPS)" (3 trials), "Olanzapine" (2 trials), "Quetiapine" (2 trials) and "Risperidone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Tuscaloosa VA Medical Center, Tuscaloosa, AL" are 43 trials for "All" genders.

Currently, there are NaN active trials in "Tuscaloosa VA Medical Center, Tuscaloosa, AL". 1 are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 31 completed trials in Tuscaloosa VA Medical Center, Tuscaloosa, AL, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Tuscaloosa VA Medical Center, Tuscaloosa, AL, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 16 trials that are defined as “Not Applicable".